Liaoning Zhonghui Biotechnology Co., Ltd. is located in the Fuxin Fluorine Industry Development Zone, Liaoning. The first phase of the project covers an area of 218 acres and is constructing an annual production project of 500 tons of pesticide raw materials, 12000 tons of pharmaceutical pesticide intermediates and by-products. Construction began at the end of March 2019 and began trial production in April 2020. Currently, the investment has exceeded 600 million yuan. The project has reached its full capacity and can achieve an annual output value of 1.5 billion yuan. The second phase of the project covers an area of 256 acres and is expected to produce 22000 tons of pesticide raw materials, 14000 tons of pharmaceutical pesticide intermediates, and by-products annually. The investment is expected to be 700 million yuan. Currently, construction has started, and the first and second phases can achieve an annual output value of 3 billion yuan after reaching full capacity. The products are mainly raw materials and intermediates of agricultural fungicides, mainly sold to Europe and America.
In 2021, the company achieved an output value of 1.38 billion yuan and a tax payment of 55.25 million yuan. Strive to achieve an output value of 1.6 billion yuan throughout 2022.
The company has been focusing on pesticide production for 20 years, originating from the designated pesticide enterprise of the Ministry of Agriculture, Rudong Zhongyi Chemical Co., Ltd. The group has multiple production bases and research and development centers in China, adhering to the principle of "people-oriented" and focusing on introducing and cultivating excellent talents while introducing advanced equipment; In the production process and product use, we pay attention to and practice the "safety, environmental protection, and green development" approach, always adhering to the concept of "safety, environmental protection, and quality are the life of the enterprise", and taking "safety, environmental protection, and quality" as the foundation of the company's survival. At the same time, the company actively engages in the research and development of new drugs, and has a complete research and development system. It has established research and development centers and special scholarships with universities and research institutions to carry out special cooperation, and continues to be committed to the exploration and development of new drugs. It has multiple patented technologies and is applying for patents. At the end of 2020, the company also purchased a research and development experimental base in Shenyang, Liaoning, Provide guarantees for talent reserves, product research and development, production, and sustainable development of enterprises.